Furthermore, a potential 2-O-Bn-InsP5-mediated inhibition of mTORC2 would also increase the inhibitory activity towards Akt, by preventing its Ser473 phosphorylation, indicating that 2-O-Bn-InsP5 represents a useful compound to be tested in cancer types specifically dependent on mTOR activation. Here, AKT1 is linked to cancer.